The Eden Prairie-based company said its motion is now “moot” after the Justice Department’s filing in late January.
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback